Arcadia Biosciences Income Statement - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.53 $0 (0.19%) RKDA stock closing price Jul 26, 2017 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Arcadia Biosciences stock price. In the income statement, an investor can check for important parameters like the topline, the bottomline, the EPS basic, dividends etc. The income statement is generated for a specific period of time. The revenue increase of $1.02M for 2017-Q1 impacts the RKDA stock. Investors typically check year over year or quarter over quarter revenue growth. The operating expenses (also check: Arcadia Biosciences assets and Arcadia Biosciences free cash flow) as shown in the Arcadia Biosciences profit and loss statement 2017-Q1 total to $4.97M. This line item has decreased from $6.05M compared with last quarter. View details of revenue and profits for Arcadia Biosciences for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4
Arcadia Biosciences Net Sales or Revenues
1.02M0.54M1.08M0.72M0.85M1.35M1.82M1.43M0.82M2.8M
Cost Of Goods Sold (COGS)0.1M0.66M0.06M0.03M0.14M0.68M0.06M0.1M0.05M0.07M
Arcadia Biosciences Gross Profit
0.91M-0.1M1.01M0.68M0.7M0.69M1.76M1.32M0.75M2.74M
Research & Development Expense1.82M2M2.25M2.21M2.2M1.88M3.17M2.08M1.83M2.08M
Selling General & Admin Expense3.05M3.39M2.68M2.75M3.43M2.89M2.81M2.78M2.63M2.3M
Income Before Depreciation Depletion Amortization-3.96M-5.49M-3.92M-4.28M-4.93M-4.08M-4.23M-3.54M-3.71M-1.64M
Depreciation Depletion Amortization----------
Non Operating Income0.09M0.11M0.09M0.07M0.07M0.67M0.28M0.73M-1.39M0.02M
Interest Expense0.33M0.34M0.33M0.32M0.32M0.66M0.76M0.77M0.46M0.36M
Arcadia Biosciences Pretax Income
-4.2M-5.71M-4.16M-4.54M-5.18M-4.07M-4.71M-3.58M-5.57M-1.97M
Provision for Income Taxes0.01M-0.01M0.01M0.01M-0.2M-0.09M0.09M0.22M0.04M
Minority Interest----------
Investment Gains Losses----------0.01M
Other Income----------
Income Before Extraordinaries & Disc Operations-4.22M-5.71M-4.18M-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M
Extraordinary Items & Discontinued Operations----------
Arcadia Biosciences Net Income (Profit/Loss)
-4.22M-5.71M-4.18M-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M
Average Shares used to compute Diluted EPS44.36M43.91M44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M
Average Shares used to compute Basic EPS44.36M43.91M44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M
Income Before Nonrecurring Items-4.22M-5.71M-4.18M-4.55M-5.19M-3.63M-4.62M-3.68M-5.8M-1.99M
Income from Nonrecurring Items------0.23M----
Arcadia Biosciences Earnings Per Share Basic Net
-0.10-0.13-0.09-0.10-0.12-0.09-0.11-0.19-3.71-1.76
Arcadia Biosciences Earnings Per Share Diluted Net
-0.10-0.13-0.09-0.10-0.12-0.09-0.11-0.19-3.71-1.76
EPS Diluted Before Nonrecurring Items-0.10-0.13-0.09-0.10-0.12-0.08-0.11-0.19-3.71-1.76
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

Arcadia Biosciences stock analysis involves checking at least a few of the important things like:
  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth (See: Arcadia Biosciences revenue chart) implies that the company is growing, which has been the case with Arcadia Biosciences. One must stay away from stocks whose revenues are declining.
  • Bottom line: The Bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $1.02M - other expenses = $-4.22M for RKDA stock. An improving bottomline implies that the company is growing profits.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Arcadia Biosciences historical stock prices to check how the price has moved with time. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
7.0105
Operating margin
-388.2
Net profit margin
-413.7
Dividend yield
0%

Other Income Statements - Arcadia Biosciences Inc Industry Peers

Tianli Agritech income statement, DuPont income statement, Dow Chemical income statement, Monsanto income statement